Back
ADMA Biologics Quote, Financials, Valuation and Earnings
![](/images/offers/ims/large/offer18.jpg)
Free video reveals how to trade 1-day options
Get the free overnight options training here.
Buy
89
ADMA
ADMA Biologics
Last Price:
11.46
Seasonality Move:
2.14%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer4.jpg)
FREE Report: Could these High Yield Stocks wreck your retirement?
Get Your Copy of "20 High-Yield Dividend Stocks that Could Ruin Your Retirement" Here.ADMA Biologics Price Quote
$11.46
ADMA Biologics Key Stats
Buy
89
ADMA Biologics (ADMA)
is a Buy
Day range:
$11.01 - $11.47
52-week range:
$3.06 - $11.68
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
9.21
P/B ratio:
17.28%
Volume:
2M
Avg. volume:
3.1M
1-year change:
216.57%
Market cap:
$2.7B
Revenue:
$258.2M
EPS:
$-0.02
How Much Does ADMA Biologics Make?
-
How Much Are ADMA Biologics's Sales Annually?
ADMA Revenues are $258.2M -
How Much Profit Does ADMA Biologics's Make A Year?
ADMA net income is -$28.2M
Is ADMA Biologics Growing As A Company?
-
What Is ADMA Biologics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.44% -
What Is ADMA Biologics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
ADMA Biologics Stock Price Performance
-
Did ADMA Biologics Stock Go Up Last Month?
ADMA Biologics share price went up by 9.25% last month -
Did ADMA's Share Price Rise Over The Last Year?
ADMA share price rose by 216.57% over the past 1 year
What Is ADMA Biologics 52-Week High & Low?
-
What Is ADMA Biologics’s 52-Week High Share Price?
ADMA Biologics has traded as high as $11.68 over the past 52 weeks -
What Is ADMA Biologics’s 52-Week Low Share Price?
ADMA Biologics has traded as low as $3.06 over the past 52 weeks
ADMA Biologics Price To Free Cash Flow
-
Is ADMA Biologics Stock Overvalued?
ADMA Biologics is trading at a price to free cash flow ratio of 163.97 -
Is ADMA Biologics Stock Undervalued?
ADMA Biologics EV to Free Cash Flow ratio is 172.38 -
What Is ADMA Biologics’s Price Earnings Growth Ratio?
ADMA PEG ratio is 0.00 -
Is ADMA Biologics Trading At A Premium To Earnings?
ADMA Biologics EV to EBIT ratio is 139.68
Is It Risky To Buy ADMA Biologics?
-
How Much Debt Does ADMA Biologics Have?
Total long term debt quarterly is $130.8M -
How Much Cash Does ADMA Biologics Have?
Cash and short term investments quarterly total is $45.3M -
What Is ADMA Biologics’s Book Value Per Share?
Book value per share is 0.66
Is ADMA Biologics Cash Flow Positive?
-
What Is ADMA Cash Flow From Operations?
Cash flow from operations (TTM) is $21.3M -
What Is ADMA Biologics’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$39.8M -
What Is ADMA Biologics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$5.4M
ADMA Biologics Return On Invested Capital
-
Is Management Doing A Good Job?
ADMA return on invested capital is -1.28% -
What Is ADMA Biologics Return On Assets?
ROA measures how assets are converting to revenues and is -1.06% -
What Is ADMA Return On Equity?
ROE is a measure of profitability and is -2.49%
ADMA Biologics Earnings Date & Stock Price
-
What Is ADMA Biologics's Stock Price Today?
A single share of ADMA can be purchased today for 11.46 -
What Is ADMA Biologics’s Stock Symbol?
ADMA Biologics trades on the nasdaq under the ticker symbol: ADMA -
When Is ADMA Biologics’s Next Earnings Date?
The next quarterly earnings date for ADMA Biologics is scheduled on August 9, 2024 -
When Is ADMA's next ex-dividend date?
ADMA Biologics's next ex-dividend date is July 8, 2024 -
How To Buy ADMA Biologics Stock?
You can buy ADMA Biologics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
ADMA Biologics Competitors
-
Who Are ADMA Biologics's Competitors?
Below is a list of companies who compete with ADMA Biologics or are related in some way:
ADMA Biologics Dividend Yield
Data Unavailable
ADMA Biologics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 60% |
Revenue: | 43.86% | 5.95% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 11.00 |
Downside from Last Price: | -4.01% |